Logo image of MCBS

METROCITY BANKSHARES INC (MCBS) Stock Fundamental Analysis

NASDAQ:MCBS - Nasdaq - US59165J1051 - Common Stock - Currency: USD

30.03  -0.58 (-1.89%)

After market: 30.03 0 (0%)

Fundamental Rating

4

Overall MCBS gets a fundamental rating of 4 out of 10. We evaluated MCBS against 405 industry peers in the Banks industry. Both the profitability and the financial health of MCBS get a neutral evaluation. Nothing too spectacular is happening here. MCBS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MCBS was profitable.
In the past year MCBS had a positive cash flow from operations.
Each year in the past 5 years MCBS has been profitable.
MCBS had a positive operating cash flow in 4 of the past 5 years.
MCBS Yearly Net Income VS EBIT VS OCF VS FCFMCBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

With an excellent Return On Assets value of 1.67%, MCBS belongs to the best of the industry, outperforming 93.23% of the companies in the same industry.
MCBS has a Return On Equity of 14.64%. This is amongst the best in the industry. MCBS outperforms 90.98% of its industry peers.
Industry RankSector Rank
ROA 1.67%
ROE 14.64%
ROIC N/A
ROA(3y)1.7%
ROA(5y)1.8%
ROE(3y)15.58%
ROE(5y)16.58%
ROIC(3y)N/A
ROIC(5y)N/A
MCBS Yearly ROA, ROE, ROICMCBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 43.68%, MCBS belongs to the best of the industry, outperforming 98.25% of the companies in the same industry.
MCBS's Profit Margin has been stable in the last couple of years.
The Operating Margin and Gross Margin are not available for MCBS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 43.68%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.72%
PM growth 5Y0.61%
GM growth 3YN/A
GM growth 5YN/A
MCBS Yearly Profit, Operating, Gross MarginsMCBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

MCBS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MCBS has more shares outstanding
Compared to 5 years ago, MCBS has less shares outstanding
There is no outstanding debt for MCBS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MCBS Yearly Shares OutstandingMCBS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
MCBS Yearly Total Debt VS Total AssetsMCBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

MCBS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC11.86%
MCBS Yearly LT Debt VS Equity VS FCFMCBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MCBS Yearly Current Assets VS Current LiabilitesMCBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

4

3. Growth

3.1 Past

MCBS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.26%, which is quite impressive.
The Earnings Per Share has been growing slightly by 7.58% on average over the past years.
Looking at the last year, MCBS shows a quite strong growth in Revenue. The Revenue has grown by 17.99% in the last year.
Measured over the past years, MCBS shows a small growth in Revenue. The Revenue has been growing by 6.95% on average per year.
EPS 1Y (TTM)24.26%
EPS 3Y1.51%
EPS 5Y7.58%
EPS Q2Q%43.18%
Revenue 1Y (TTM)17.99%
Revenue growth 3Y0.77%
Revenue growth 5Y6.95%
Sales Q2Q%14.75%

3.2 Future

MCBS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.92% yearly.
The Revenue is expected to grow by 5.67% on average over the next years.
EPS Next Y4.15%
EPS Next 2Y5.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.61%
Revenue Next 2Y5.67%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MCBS Yearly Revenue VS EstimatesMCBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MCBS Yearly EPS VS EstimatesMCBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

MCBS is valuated reasonably with a Price/Earnings ratio of 11.96.
Based on the Price/Earnings ratio, MCBS is valued a bit cheaper than 60.15% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.62, MCBS is valued rather cheaply.
A Price/Forward Earnings ratio of 11.49 indicates a reasonable valuation of MCBS.
MCBS's Price/Forward Earnings ratio is in line with the industry average.
MCBS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.96
Fwd PE 11.49
MCBS Price Earnings VS Forward Price EarningsMCBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MCBS indicates a slightly more expensive valuation: MCBS is more expensive than 70.68% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.35
EV/EBITDA N/A
MCBS Per share dataMCBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.88
PEG (5Y)1.58
EPS Next 2Y5.92%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

MCBS has a Yearly Dividend Yield of 3.01%.
MCBS's Dividend Yield is comparable with the industry average which is at 3.19.
MCBS's Dividend Yield is a higher than the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 3.01%

5.2 History

MCBS has been paying a dividend for at least 10 years, so it has a reliable track record.
MCBS has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)N/A
Div Incr Years8
Div Non Decr Years8
MCBS Yearly Dividends per shareMCBS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

MCBS pays out 33.09% of its income as dividend. This is a sustainable payout ratio.
DP33.09%
EPS Next 2Y5.92%
EPS Next 3YN/A
MCBS Yearly Income VS Free CF VS DividendMCBS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
MCBS Dividend Payout.MCBS Dividend Payout, showing the Payout Ratio.MCBS Dividend Payout.PayoutRetained Earnings

METROCITY BANKSHARES INC

NASDAQ:MCBS (2/21/2025, 8:00:01 PM)

After market: 30.03 0 (0%)

30.03

-0.58 (-1.89%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-21 2025-01-21/bmo
Earnings (Next)04-17 2025-04-17/bmo
Inst Owners24.55%
Inst Owner Change-90.46%
Ins Owners26.46%
Ins Owner Change0.13%
Market Cap762.76M
Analysts43.33
Price Target36.72 (22.28%)
Short Float %0.56%
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield 3.01%
Yearly Dividend0.72
Dividend Growth(5Y)N/A
DP33.09%
Div Incr Years8
Div Non Decr Years8
Ex-Date01-29 2025-01-29 (0.23)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.22%
Min EPS beat(2)-1.05%
Max EPS beat(2)9.49%
EPS beat(4)2
Avg EPS beat(4)0.89%
Min EPS beat(4)-10.13%
Max EPS beat(4)9.49%
EPS beat(8)4
Avg EPS beat(8)0.08%
EPS beat(12)6
Avg EPS beat(12)-0.63%
EPS beat(16)10
Avg EPS beat(16)1.8%
Revenue beat(2)1
Avg Revenue beat(2)2.11%
Min Revenue beat(2)-0.05%
Max Revenue beat(2)4.28%
Revenue beat(4)3
Avg Revenue beat(4)2.88%
Min Revenue beat(4)-0.05%
Max Revenue beat(4)5.33%
Revenue beat(8)5
Avg Revenue beat(8)-0.37%
Revenue beat(12)6
Avg Revenue beat(12)-1.34%
Revenue beat(16)10
Avg Revenue beat(16)0.68%
PT rev (1m)0%
PT rev (3m)12.5%
EPS NQ rev (1m)0.82%
EPS NQ rev (3m)0.82%
EPS NY rev (1m)-1.42%
EPS NY rev (3m)-1.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE 11.96
Fwd PE 11.49
P/S 5.59
P/FCF 22.35
P/OCF 21.23
P/B 1.87
P/tB 1.91
EV/EBITDA N/A
EPS(TTM)2.51
EY8.36%
EPS(NY)2.61
Fwd EY8.71%
FCF(TTM)1.34
FCFY4.47%
OCF(TTM)1.41
OCFY4.71%
SpS5.37
BVpS16.03
TBVpS15.69
PEG (NY)2.88
PEG (5Y)1.58
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 14.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 43.68%
GM N/A
FCFM 25%
ROA(3y)1.7%
ROA(5y)1.8%
ROE(3y)15.58%
ROE(5y)16.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y0.72%
PM growth 5Y0.61%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 62.63%
Cap/Sales 1.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 57.23%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC11.86%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.26%
EPS 3Y1.51%
EPS 5Y7.58%
EPS Q2Q%43.18%
EPS Next Y4.15%
EPS Next 2Y5.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.99%
Revenue growth 3Y0.77%
Revenue growth 5Y6.95%
Sales Q2Q%14.75%
Revenue Next Year3.61%
Revenue Next 2Y5.67%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-55.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.92%
OCF growth 3YN/A
OCF growth 5YN/A